Vaccines against sterols

Details Vaccines against sterols Vaccines against sterols

1995-04-14

1998-05-19

Achutamurthy, Ponnathapura

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

4241841, A61K 927, A61K 3900

Patent

active

057532605

ABSTRACT:
The present invention relates to immunoreactive compositions and methods for immunizing humans or animals against sterols, such as cholesterol and its derivatives, and their use in methods for reducing the serum cholesterol levels of the immunized individuals and to retard or reduce the severity of atherosclerosis or atherosclerosis plaques caused by ingestion of dietary cholesterol. Another embodiment of the present invention encompasses ergosterol or ergosterol derivative compositions useful for the treatment or prevention of fungal infection, and methods of use thereof. Yet another aspect of the invention is dairy products containing anti-ergosterol antibodies produced by dairy animals immunized against ergosterol according to the present invention and methods of making thereof. A further aspect of the invention is a diagnostic assay for determining whether a human or animal has a fungal infection.

REFERENCES:
patent: 4241046 (1980-12-01), Papahadjopoulos et al.
patent: 4767720 (1988-08-01), Lingwood
patent: 4885256 (1989-12-01), Alving et al.
patent: 4952569 (1990-08-01), Simons
patent: 5026557 (1991-06-01), Estis et al.
patent: 5100662 (1992-03-01), Bolcsak et al.
van Dalen et al (1988) J. Controlled Release 1:123-132.
New, R.R.C., et al., "Antileishmanial acitivity of amphotericin and other antifungal agents entrapped in liposomes," Journal of Antimicrobial Chemotherapy, vol. 8, pp. 371-381 (1981).
Taylor, R.L., et al., "Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis," Am. Rev. Respir. Dis., vol. 125, pp. 610-611 (1982).
Graybill, J.R. et al., "Treatment of Murine Cryptococcosis with Liposome-Associated Amphotericin B," The Journal of Infectious Diseases, vol. 145, No. 5, pp. 748-752 (May 1982).
Lopez-Berestein, G. et al., "Effects of Sterols on the Therapeutic Efficacy of Liposomal Amphotericin B in Murine Candidiasis," Cancer Drug Delivery, vol. 1, No. 1, pp. 37-42 (1983).
Ahrens, J. et al, "Treatment of Experimental Murine Candidiasis with Liposome-associated Amphotericin B," Sabouraudia: Journal of Medical and Veterinary Mycology, vol. 22, pp. 163-166 (1984).
Hopfer, R.L. et al., "In Vitro Antifungal Activities of Amphotericin B and Liposome-Encapsulated Amphotericin B," Antimicrobial Agents and Chemotherapy, vol. 25, No. 3, pp. 387-389 (Mar. 1984).
Mehta, R. et al., "Liposomal Amphotericin B Is Toxic To Fungal Cells But Not To Mammalian Cells," Biochimica et Biophysica Acta, vol. 77, pp. 230-234 (1984).
Juliano, R. et al., "Pharmacokinetic and Therapeutic Consequences of Liposomal Drug Delivery: Fluorodeoxyuridine and Amphotericin B as Examples," Biology of the Cell, vol. 47 pp. 39-46 (1983).
Berger, E. et al., "On the Specificity of Antibodies to Substances from the Lipoid Class," Z. Immunitaet, vol. 76 pp. 16-35 (1932).
Wadsworth, A. et al., "The Antigenic Action of Cholesterol," Journal of Immunobiology, vol. 29, pp. 135-149 (1935).
Wiseman, H. et al., "Mechanism of Inhibition of Lipid peroxidation by Tamoxifen and 4-hydroxytamoxifen Introduced to Liposomes," FEBS Letters, vol. 274, No. 1,2, pp. 107-110 (Nov. 1990).
Alving, C.R. et al., "Antibodies to Cholesterol, Cholesterol Conjugates, and Liposomes: Implications for Atherosclerosis and Autoimmunity," Critical Reviews in Immunology, vol. 10, Issue 5, pp. 441-453 (1991).
Franek, Milan, "Structural Aspects of Steroid-Antibody Specificity," Journal of Steroid Biochemistry, vol. 28, No. 1, pp. 95-108 (1987).
Fantl, V.E et al., "Production and Characterization of a Monoclonal Antibody to Progesterone," Journal of Steroid Biochemistry, vol. 14, pp. 405-107 (1981).
Fantl, V.E. et al., "Characterization of Monoclonal Antibodies Raised Against Testosterone," Journal of Steroid Biochemistry, vol. 19, No. 5, pp. 1605-1610 (1983).
Fantl, V.E. et al., "Simultaneous Production of Monoclonal Antibodies to Dehydroepiandrosterone, Ostradiol Progesterone and Testosterone," Journal of Endrocrinology, vol. 100, pp. 367-376 (1984).
Brochu, M. et al., "Monoclonal Antibodies for Use with Iodine-Labeled Radioligands in Progesterone Radioimmunoassay," Journal of Steroid Biochemistry, vol. 21, No. 4 pp. 405-411 (1984).
Klopstock, A. et al., "Antibodies Reacting with Steroid Haptens," Journal of Immunology, vol. 92, pp. 515-519 (1964).
Swartz, Jr., G.M. et al., "Antibodies to Cholesterol," Proc. National Academy of Sciences, vol. 85, pp. 1902-1906 (Mar. 1988).
Alving, C.R. et al., "Naturally Occurring Autoantibodies to Cholesterol in Humans," Biochemical Transactions, 629th Meeting, London, vol. 17, pp. 637-639 (1989).
Gerlier, D. et al., "Liposomes as a Tool to Study the Role of Membrane Presentation in the Immunogenicity of a MuL V-Related Tumor Antigen," The Journal of Immunology, vol. 131, No. 1, pp. 485-490 (Jul. 1983).
Bangham, A.D. et al., "Diffusion of Univalent Ions Across the Lamellae of Swollen Phospholipids," Journal of Molecular Biology, vol. 13, pp. 238-252 (1965).
Bruckdorfer, K.R. et al., "The Incorporation of Steroid Molecules into Lecithin Sols, .beta.-Lipoproteins and Cellular Membranes," European Journal of Biochemistry, vol. 4, pp. 512-518 (1968).
Bruckdorder, K.R. et al., "The Effect of Partial Replacements of Membrane Cholesterol by Other Steroids on the Osmotic Fragility and Glycerol Permeability of Erythrocytes," Bichimica et Biophysica Acta, vol. 183, pp. 334-335 (1969).
Banerji, B. et al., "Antibodies to Liposomal Phosphatidylserine and Phosphatidic Acid," Biochemical Cell Biology, vol. 68, pp. 96-100 (1990).
Alving, C. et al., "Cholesterol-Dependent Human Complement Activation Resulting In Damage To Liposomal Model Membrane," The Journal of Immunology, vol. 118, No. 1, pp. 342-347 (Jan., 1977).
Bailey, J.M. et al., "Immunization with a Synthetic Cholesterol-ester Antigen and Induced Atherosclerosis in Rabbits," Nature, vol. 201, No. 4917, pp. 407-408 (Jan. 25, 1964).
Brown, M.S. et al., "A Receptor-Mediated Pathway for Cholesterol Homeostatis," Science, vol. 232, pp. 34-47 (Apr. 4, 1986).
Sato, J. et al., "Anti-cholesterol Activity in Antisera Against Human Serum Lipoprotiens," Immunochemistry, vol. 9, No. 5, pp. 585-587 (May, 1972).
Banerji, B. et al., "Membrane Lipid Composition Modulates the Binding Specificity of a Monoclonal Antibody Against Liposomes," Biochimia et Biophysica Acta, vol. 689, pp. 319-326 (1982).
Rook, G., "Immunity to Viruses, Bacteria and Fungi," Immunology, The C.V. Mosby Company, St. Louis, pp. 16.14-16.15 (1989).
Playfair, J.H.L., "Vaccines: Still Needed," Immune Intervention, Academic Press, London, pp. 1-12 (1984).
Fries, L.F., et al., "Liposomal Malaria Vaccine in Humans: A Safe and Potent Adjuvant Strategy," Proc. National Academy of Sciences, vol. 89, pp. 358-362 (Jan. 1992).
Langer, R., "New Methods of Drug Delivery," Science, vol. 249, pp. 1527-1533 (Sep. 28, 1990).
Alving, C.R., et al., "Adjuvanticity of Lipid A and Lipid A Fractions in Liposomes," Liposome and Immunobiology, Elsevier North Holland, Inc., New York, pp. 67-78 (1980).
Klimov et al., "Cholesterol Metabolism in Rabbits with Resistance to Experimental Atherosclerosis Aquired by Immunological Treatment," Vopr. Med. Khim., vol. 6, pp. 803-807 (1977) (abstract in English).
Sato et al., "Anticholeseremic antibody," Chemical Abstracts, vol. 83, No. 18, abstract No. 152332m (1975).
Alving et al., "Liposomes as vehicles for vaccines," Prog. Clin. Biol. Res., vol. 47, pp. 339-355 (1980).
Goodman, D.S. et al., "Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults," Arch. Intern, Med., vol. 148, pp. 36-69 (1988).
Kromhout, D. et al., "Serum cholesterol and 25-year incidence of and mortality from myocardial infraction and cancer," Arch Intern, Med., vol. 148, pp. 1051-1055 (1988).
Luepker, R.V. et al., "Recommendations regarding public screening for measuring blood cholesterol. Summary of a National Heart, Lung and Blood Institute Workshop (Oct. 1988)," Arch. Intern. Med., vol. 149, pp. 2650-2654 (1989).
Alving, "Antibodies to liposomes, phospholipids and cholesterol: Implications for autoimmunity, atherosclerosis and agi

Affiliated with

Also associated with

Rating

Vaccines against sterols does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccines against sterols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines against sterols will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1850584